List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 174 studies with search of:   "Lopinavir"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs;   Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs;   Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs;   Drug: lopinavir/ritonavir cap (tablet or capsule) with NRTIs
2 Completed A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir;   Drug: lopinavir/ritonavir
3 Recruiting Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Lopinavir/ritonavir;   Drug: Lopinavir/ritonavir
4 Recruiting Lopinavir/Ritonavir (Kaletra)PK
Conditions: HIV/AIDS Treatment;   HIV Infections
Interventions: Drug: lopinavir/ritonavir (Kaletra®) tablets;   Drug: lopinavir/ritonavir (Kaletra®) tablets
5 Terminated Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Conditions: HIV Infections;   Kaletra
Interventions: Drug: lopinavir/ritonavir;   Drug: lopinavir /ritonavir
6 Recruiting Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
7 Completed Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir;   Drug: lamivudine/zidovudine
8 Active, not recruiting A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Conditions: HIV;   Tuberculosis
Interventions: Drug: lopinavir/ritonavir;   Drug: rifabutin
9 Recruiting Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lopinavir / ritonavir;   Drug: Lopinavir/ritonavir
10 Recruiting Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
Condition: HIV Infections
Interventions: Drug: Lumefantrine - lopinavir/ritonavir drug interaction;   Drug: Lumefantrine only arm
11 Terminated Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV co-Infected Subjects vs Baseline Liver Biopsy Metavir Score
Condition: HIV Infection
Intervention: Drug: Lopinavir/Ritonavir
12 Completed Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: Tenofovir DF;   Drug: lopinavir/ritonavir with 2 Nucleoside RTIs
13 Recruiting ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
Condition: HIV-1
Interventions: Drug: Truvada (emtricitabine 200 mg/tenofovir DF 300 mg) and Kaletra (lopinavir 200 mg/ritonavir;   Drug: Kivexa (abacavir (as sulfate) 600 mg/lamivudine and Kaletra (lopinavir 200 mg/ritonavir
14 Recruiting TDM of Generic Lopinavir/Ritonavir 200/50 mg
Condition: HIV
Intervention: Drug: generic lopinavir/ritonavir
15 Completed ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Lamivudine;   Drug: Stavudine
16 Not yet recruiting Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women
Condition: HIV Infections
Intervention: Drug: generic lopinavir/ritonavir
17 Recruiting Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-Partum Phase. ANRS 135 Primeva
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)
18 Active, not recruiting Raltegravir Insulin Sensitivity Study
Condition: HIV Infections
Interventions: Drug: Raltegravir then lopinavir/ritonavir;   Drug: Lopinavir/ritonavir then raltegravir
19 Active, not recruiting Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants
Condition: HIV Infections
Intervention: Drug: Lopinavir/Ritonavir
20 Completed Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil
Conditions: HIV Infections;   Cholesterol
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Gemfibrozil

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services